Edition:
United States

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

293.50SEK
6:31am EST
Change (% chg)

-0.50kr (-0.17%)
Prev Close
294.00kr
Open
291.00kr
Day's High
294.00kr
Day's Low
291.00kr
Volume
1,449
Avg. Vol
17,529
52-wk High
302.00kr
52-wk Low
197.00kr

BIOGb.ST

Chart for BIOGb.ST

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 1.08
Market Cap(Mil.): kr4,879.16
Shares Outstanding(Mil.): 16.60
Dividend: 3.03
Yield (%): 1.70

Financials

  BIOGb.ST Industry Sector
P/E (TTM): 36.97 26.36 40.41
EPS (TTM): 7.95 -- --
ROI: 36.97 12.71 59.88
ROE: 37.11 16.60 67.66

BRIEF-Biogaia Q3 operating profit increases

* Biogaia q3 operating profit excluding IBT was SEK 48.4 million (36.2) Source text for Eikon: Further company coverage: (Reporting By Johan Ahlander)

Oct 25 2016

BRIEF-Biogaia says probiotics to be launched in Kenya, Nigeria and Ghana

* Has signed an exclusive distributor agreement with Phillips Pharma Group for the rights to sell Biogaia Protectis drops, tablets and Oral Rehydration Solution in Kenya, Nigeria and Ghana.

Sep 14 2016

Earnings vs. Estimates